Goldman Sachs is maintaining its overweight calls on China H-shares and A-shares — those listed in Hong Kong and on the ...

Hedge funds have "reversed course" since mid-February, Goldman Sachs prime brokerage said. The investment bank said China had ...

Goldman Sachs raised its target price for emerging markets stocks on Thursday, projecting that the AI-powered rally in ...

Consumer prices in China have plunged to their lowest level in more than a year, highlighting persistent deflationary pressures in the world’s second-largest economy.

Kinger Lau, chief China strategist at Goldman Sachs, says artificial intelligence could "raise the fair value for Chinese ...

After Goldman Sachs downgraded US growth forecasts and J.P. Morgan’s chief economist Bruce Kasman raised recession risks to ...

Hedge funds reduce China equity exposure for the 4th week, with macro products & single stocks leading sales. Explore the ...

CHINA: China's consumer inflation dropped more than expected, falling below zero for the first time in 13 months, reflecting ...

On the financial side, Goldman Sachs has made modest upward revisions to its estimates for Carl Zeiss Meditec. EBITA forecasts have been raised by 0-3% for FY25-27, driven by higher expected revenues ...

Investing.com -- Goldman Sachs raised rating on GE HealthCare Technologies Inc (NASDAQ: GEHC) to "Buy" from "Neutral” as ...

Global hedge funds continued to sell China equities for a fourth straight week as the renewed enthusiasm for Chinese tech ...

According to Goldman Sachs, consumer inflation in China dropped to the weakest levels in past few months, even after taking ...